Sitemap

Medical science

12/2005 Combined sonographic and endoscopic umbilical cord occlusion in twin and triplet gestations

12/2005 Regional difference of endothelium-dependent contractility in human umbilical artery

12/2005 Isolated echogenic intracardiac foci in patients with low-risk triple screen results: assessing the risk of Trisomy 21

12/2005 Neonatal screening for congenital hypothyroidism in Hessen, Germany: efficiency of the screening program and school achievement of 129 children at an age of 8–12 years

12/2005 Utility of a Doppler-derived index combining systolic and diastolic performance (Tei index) for detecting hypoxic cardiac damage in newborns

12/2005 Breast-feeding in women with hypertensive disorders in pregnancy

12/2005 Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin

12/2005 Failure of conservative management of placenta previa-percreta

12/2005 The new role of D-dimer as a predictor of recurrent venous thromboembolism D-Dimere: Ihre neue Rolle als Prädiktoren für rezidivierende venöse Thromboembolien

12/2005 Plasminogen activator inhibitor-1: a review Plasminogen-Aktivator-Inhibitor-1: eine Übersicht

12/2005 TAFI: regulating the cross talk between coagulation and fibrinolysis TAFI: Regulierung der Wechselwirkung zwischen Gerinnung und Fibrinolyse

12/2005 ZNS-Proteine im Liquor: Einflussfaktoren auf ihre Konzentration im Liquor und klinische Relevanz Brain specific proteins in cerebrospinal fluid (CSF): factors influencing their concentration in CSF and clinical relevance

12/2005 Die Wertigkeit der quantitativen und qualitativen IgG Analyse im Liquor Quality rating of quantitative and qualitative IgG analysis in liquor

12/2005 Mikrobiologische Liquor-Diagnostik Microbiological diagnostics in CSF

12/2005 Laboratory diagnosis of toxoplasmosis – possibilities and limitations Die Labordiagnose der Toxoplasmose – Möglichkeiten und Grenzen

12/2005 Die Diagnostik von Infektionen mit freilebenden Amöben (FLA) Diagnostics of Infections with free-living amoebae (FLA)

12/2005 Analyse natürlicher Autoantikörper-Repertoires im Humansystem – Ein systembiologisch orientierter Ansatz zum Verständnis Immunglobulin-vermittelter Immunregulation Analysis of natural autoantibody repertoires in humans – investigation of immun

01/2006 50 years GTH expectations, progress, disappointments. A personal perspective

01/2006 Current and future prospects in haemostasis

01/2006 The management of patients with heparin-induced thrombocytopenia

01/2006 Global tests of haemostasis

01/2006 Quantification of coagulation factors and inhibitors. Still a special task

01/2006 Primary haemostasis and its assessment by laboratory tests

01/2006 Idiopathic venous thrombosis. Long-term anticoagulation therapy? Yes

01/2006 Idiopathic venous thrombosis. Long-term anticoagulant therapy? No

01/2006 Inhibition of platelet aggregation for the secondary prevention after ACS: When clopidogrel instead of ASA, when clopidogrel and ASA?

01/2006 Thrombophilia and pregnancy complications

01/2006 Pregnancy-associated venous thromboembolic disease: prediction, prevention, and therapy

01/2006 Thrombocytopenia during pregnancy. Importance, diagnosis and management

01/2006 Pathophysiology of acute coronary syndrome

01/2006 Haemostasis and antithrombotic drugs: pharmacology and novel therapeutic approaches

01/2006 Antithrombotic therapy for non-ST segment elevation myocardial infarction

01/2006 The role of platelets for the pathophysiology of acute coronary syndromes

01/2006 Platelet inhibitors from a cardiological viewpoint: evidence based therapy and new concepts for the acute coronary syndrome without ST-segment elevation

01/2006 Role of the vascular wall in the pathophysiology of the acute coronary syndrome

01/2006 Acute ST-elevation myocardial infaction: Is primary PCI superior to thrombolysis?

01/2006 Acute coronary syndrome: peri-interventional antithrombotic therapy

01/2006 Tissue factor in acute coronary syndromes

01/2006 Inhibition of plasmatic coagulation: What is new?

01/2006 Primary and secondary prevention of the acute coronary syndrom

01/2006 Epidemiology of peripheral arterial disease in Germany. What is evident, what remains unclear?

01/2006 Mutation in factor II and factor V gene in patients with peripheral arterial occlusive disease

01/2006 Markers predicting progression of disease in PAD: Which of them are both relevant to clinical practice and economically justifiable?

01/2006 Are the TASC recommendations for diagnosis and treatment of PAOD still relevant?

01/2006 Systemic and regional fibrinolytic treatment of peripheral arterial occlusions: Proven indications?

01/2006 Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions

01/2006 Is the generally accepted therapeutic benefit of exercise training in patients with peripheral arterial occlusive disease evidence based? Analysis of the Cochrane review

01/2006 Resistance to acetylsalicylic acid and clopidogrel: current status

01/2006 Longterm treatment of POAD with anticoagulants and platelet inhibitors after endovascular procedures and vascular surgery: What is evidence based?

01/2006 Gene therapy and stem cell transplantation in PAD

01/2006 Perioperative management of coagulation

01/2006 Dilutional coagulopathy: development, diagnostic options and management

01/2006 Possibilities and limitations of thrombelastometry/-graphy

01/2006 Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy

01/2006 Safety of plasma-derived factor concentrates: an example of pharmacovigilance with fibrinogen and factor XIII-concentrate

01/2006 Modern anaesthesiological techniques and anticoagulation

01/2006 Coagulation management in major trauma

01/2006 Haemorrhagic complications in obstetrics

01/2006 Coagulation management during liver transplantation

01/2006 Bleeding after cardiac surgery: the role of recombinant factor VIIa

01/2006 Stroke: epidemiology, risk factors, and genetics

01/2006 Stroke: causes and classification

01/2006 Coagulation disorders and stroke

01/2006 Therapy of acute stroke

01/2006 Endovascular therapy of stroke

01/2006 Secondary prevention of stroke

01/2006 Acquired von Willebrand syndrome in two children with congenital heart defects and abnormal haemodynamics

01/2006 Assessing Information Technologies for Health. Editorial

01/2006 Assessment of Education and Research in Biomedical Informatics

01/2006 Evaluation and Implementation: A Call for Action

Back

Publisher and Institutes

Sitemap

Medical science